Blair Jordan, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated February 28, 2024, indicates that Jordan does not beneficially own any securities at the time of the report. The form, signed on March 12, 2024, is a standard disclosure for directors and significant shareholders, detailing ownership stakes in the company. This filing is part of the regulatory requirements under Section 16(a) of the Securities Exchange Act of 1934, which mandates insiders to report changes in ownership to the SEC.

Blair Jordan, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated February 28, 2024, indicates that Jordan does not beneficially own any securities at the time of the report. The form, signed on March 12, 2024, is a standard disclosure for directors and significant shareholders, detailing ownership stakes in the company. This filing is part of the regulatory requirements under Section 16(a) of the Securities Exchange Act of 1934, which mandates insiders to report changes in ownership to the SEC.